HLS Therapeutics Inc. (HLS.TO)
CAD 4.24
(-0.7%)
CAD 4.24
(-0.7%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 55.45 Million USD | -1.83% |
| 2022 | 56.48 Million USD | 0.8% |
| 2021 | 56.03 Million USD | 6.77% |
| 2020 | 52.48 Million USD | 0.49% |
| 2019 | 52.22 Million USD | -11.21% |
| 2018 | 58.82 Million USD | -17.09% |
| 2017 | 70.94 Million USD | 31.05% |
| 2016 | 54.13 Million USD | 168.38% |
| 2015 | 20.17 Million USD | -3.25% |
| 2014 | 20.84 Million USD | 22.92% |
| 2013 | 16.96 Million USD | -32.51% |
| 2012 | 25.12 Million USD | 22.55% |
| 2011 | 20.5 Million USD | 16.16% |
| 2010 | 17.65 Million USD | 65.51% |
| 2009 | 10.66 Million USD | -7.25% |
| 2008 | 11.49 Million USD | -38.59% |
| 2007 | 18.72 Million USD | 483.76% |
| 2006 | 3.2 Million USD | -25.7% |
| 2005 | 4.31 Million USD | -6.71% |
| 2004 | 4.62 Million USD | -49.14% |
| 2003 | 9.09 Million USD | 61.76% |
| 2002 | 5.62 Million USD | -1.77% |
| 2001 | 5.72 Million USD | 10.94% |
| 2000 | 5.16 Million USD | -23.71% |
| 1999 | 6.76 Million USD | 131.37% |
| 1998 | 2.92 Million USD | 13.11% |
| 1997 | 2.58 Million USD | 83.41% |
| 1996 | 1.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 12.21 Million USD | 14.18% |
| 2024 Q1 | 10.69 Million USD | -19.74% |
| 2023 FY | 55.45 Million USD | -1.83% |
| 2023 Q1 | 13.31 Million USD | -5.97% |
| 2023 Q2 | 14.64 Million USD | 9.97% |
| 2023 Q3 | 14.16 Million USD | -3.23% |
| 2023 Q4 | 13.33 Million USD | -5.91% |
| 2022 Q1 | 13.6 Million USD | -6.62% |
| 2022 FY | 56.48 Million USD | 0.8% |
| 2022 Q3 | 14.34 Million USD | -0.22% |
| 2022 Q2 | 14.37 Million USD | 5.7% |
| 2022 Q4 | 14.15 Million USD | -1.32% |
| 2021 Q3 | 13.88 Million USD | -1.2% |
| 2021 Q1 | 13.54 Million USD | -10.77% |
| 2021 FY | 56.03 Million USD | 6.77% |
| 2021 Q2 | 14.04 Million USD | 3.76% |
| 2021 Q4 | 14.56 Million USD | 4.96% |
| 2020 Q3 | 12.3 Million USD | 3.11% |
| 2020 Q4 | 15.17 Million USD | 23.32% |
| 2020 Q2 | 11.93 Million USD | -8.7% |
| 2020 FY | 52.48 Million USD | 0.49% |
| 2020 Q1 | 13.07 Million USD | -2.84% |
| 2019 Q1 | 12.78 Million USD | -20.44% |
| 2019 Q2 | 13.1 Million USD | 2.48% |
| 2019 FY | 52.22 Million USD | -11.21% |
| 2019 Q4 | 13.45 Million USD | 4.38% |
| 2019 Q3 | 12.88 Million USD | -1.63% |
| 2018 Q2 | 15.76 Million USD | 25.29% |
| 2018 FY | 58.82 Million USD | -17.09% |
| 2018 Q4 | 16.06 Million USD | 11.62% |
| 2018 Q3 | 14.39 Million USD | -8.71% |
| 2018 Q1 | 12.58 Million USD | -82.26% |
| 2017 Q1 | 14.22 Million USD | -9.95% |
| 2017 FY | 70.94 Million USD | 31.05% |
| 2017 Q4 | 70.94 Million USD | 317.48% |
| 2017 Q3 | 16.99 Million USD | -2.92% |
| 2017 Q2 | 17.5 Million USD | 23.09% |
| 2016 Q3 | 106.48 Thousand USD | 0.0% |
| 2016 FY | 54.13 Million USD | 168.38% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q4 | 15.79 Million USD | 14731.97% |
| 2015 Q2 | 385.88 Thousand USD | 160.47% |
| 2015 Q3 | 199.62 Thousand USD | -48.27% |
| 2015 Q4 | 260.92 Thousand USD | 30.71% |
| 2015 FY | 20.17 Million USD | -3.25% |
| 2015 Q1 | -638.11 Thousand USD | -108.76% |
| 2014 FY | 20.84 Million USD | 22.92% |
| 2014 Q4 | 7.28 Million USD | 31.97% |
| 2014 Q1 | 5.14 Million USD | 6.35% |
| 2014 Q2 | 3.09 Million USD | -39.93% |
| 2014 Q3 | 5.51 Million USD | 78.47% |
| 2013 Q3 | 4.29 Million USD | 117.38% |
| 2013 Q1 | 5.89 Million USD | 15.18% |
| 2013 FY | 16.96 Million USD | -32.51% |
| 2013 Q4 | 4.83 Million USD | 12.64% |
| 2013 Q2 | 1.97 Million USD | -66.46% |
| 2012 Q4 | 5.11 Million USD | -21.92% |
| 2012 FY | 25.12 Million USD | 22.55% |
| 2012 Q3 | 6.55 Million USD | -6.84% |
| 2012 Q2 | 7.03 Million USD | 14.96% |
| 2012 Q1 | 6.11 Million USD | 18.15% |
| 2011 Q1 | 6.08 Million USD | 6.89% |
| 2011 Q2 | 5.37 Million USD | -11.54% |
| 2011 Q3 | 4.61 Million USD | -14.23% |
| 2011 Q4 | 5.17 Million USD | 12.19% |
| 2011 FY | 20.5 Million USD | 16.16% |
| 2010 Q2 | 6.46 Million USD | 42.28% |
| 2010 FY | 17.65 Million USD | 65.51% |
| 2010 Q1 | 4.54 Million USD | 12.65% |
| 2010 Q4 | 5.68 Million USD | 550.0% |
| 2010 Q3 | 875.17 Thousand USD | -86.46% |
| 2009 Q3 | 526.7 Thousand USD | -90.51% |
| 2009 Q2 | 5.55 Million USD | 267.26% |
| 2009 FY | 10.66 Million USD | -7.25% |
| 2009 Q4 | 4.03 Million USD | 665.46% |
| 2009 Q1 | 1.51 Million USD | 157.06% |
| 2008 FY | 11.49 Million USD | -38.59% |
| 2008 Q4 | 588.13 Thousand USD | -86.97% |
| 2008 Q3 | 4.51 Million USD | 3.77% |
| 2008 Q2 | 4.35 Million USD | 91.12% |
| 2008 Q1 | 2.27 Million USD | -48.18% |
| 2007 Q1 | 3.73 Million USD | 1529.62% |
| 2007 FY | 18.72 Million USD | 483.76% |
| 2007 Q4 | 4.39 Million USD | 6.83% |
| 2007 Q3 | 4.11 Million USD | -25.07% |
| 2007 Q2 | 5.48 Million USD | 46.97% |
| 2006 Q1 | 1.12 Million USD | -26.33% |
| 2006 Q2 | 879.55 Thousand USD | -21.91% |
| 2006 Q3 | 180.9 Thousand USD | -79.43% |
| 2006 Q4 | 229.1 Thousand USD | 26.64% |
| 2006 FY | 3.2 Million USD | -25.7% |
| 2005 Q2 | 1.16 Million USD | 938.31% |
| 2005 Q3 | 1.44 Million USD | 23.49% |
| 2005 Q4 | 1.52 Million USD | 6.05% |
| 2005 Q1 | 112.42 Thousand USD | 326.32% |
| 2005 FY | 4.31 Million USD | -6.71% |
| 2004 Q3 | 390.9 Thousand USD | -77.23% |
| 2004 Q4 | 26.37 Thousand USD | -93.25% |
| 2004 FY | 4.62 Million USD | -49.14% |
| 2004 Q1 | 2.3 Million USD | -4.39% |
| 2004 Q2 | 1.71 Million USD | -25.48% |
| 2003 Q1 | 2.13 Million USD | 54.31% |
| 2003 FY | 9.09 Million USD | 61.76% |
| 2003 Q4 | 2.4 Million USD | 117.95% |
| 2003 Q3 | 1.1 Million USD | -66.31% |
| 2003 Q2 | 3.28 Million USD | 54.0% |
| 2002 FY | 5.62 Million USD | -1.77% |
| 2002 Q4 | 1.38 Million USD | 15.82% |
| 2002 Q3 | 1.19 Million USD | -30.02% |
| 2002 Q2 | 1.7 Million USD | 20.39% |
| 2002 Q1 | 1.41 Million USD | -9.68% |
| 2001 Q1 | 1.64 Million USD | 258.94% |
| 2001 FY | 5.72 Million USD | 10.94% |
| 2001 Q4 | 1.56 Million USD | 41.55% |
| 2001 Q3 | 1.1 Million USD | -24.36% |
| 2001 Q2 | 1.46 Million USD | -11.18% |
| 2000 Q2 | 1.95 Million USD | -5.2% |
| 2000 Q1 | 2.06 Million USD | 19.56% |
| 2000 FY | 5.16 Million USD | -23.71% |
| 2000 Q4 | -1.03 Million USD | -145.64% |
| 2000 Q3 | 2.27 Million USD | 16.03% |
| 1999 Q4 | 1.72 Million USD | -23.13% |
| 1999 Q2 | 1.62 Million USD | 44.51% |
| 1999 Q1 | 1.12 Million USD | -30.21% |
| 1999 FY | 6.76 Million USD | 131.37% |
| 1999 Q3 | 2.24 Million USD | 38.03% |
| 1998 FY | 2.92 Million USD | 13.11% |
| 1998 Q4 | 1.61 Million USD | 305.36% |
| 1998 Q2 | 612.62 Thousand USD | -62.19% |
| 1998 Q1 | 1.62 Million USD | 0.0% |
| 1998 Q3 | -786.11 Thousand USD | -228.32% |
| 1997 Q3 | 1.27 Million USD | -23.47% |
| 1997 FY | 2.58 Million USD | 83.41% |
| 1997 Q2 | 1.66 Million USD | 37.27% |
| 1997 Q1 | 1.21 Million USD | 0.0% |
| 1996 FY | 1.4 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aurora Cannabis Inc. | 131.46 Million CAD | 57.82% |
| Avicanna Inc. | 6.65 Million CAD | -732.746% |
| Avant Brands Inc. | 12.43 Million CAD | -346.026% |
| Cardiol Therapeutics Inc. | -248.35 Thousand CAD | 22426.911% |
| Crescita Therapeutics Inc. | 10.36 Million CAD | -435.025% |
| Knight Therapeutics Inc. | 152.65 Million CAD | 63.676% |
| MediPharm Labs Corp. | 5.85 Million CAD | -847.054% |
| OrganiGram Holdings Inc. | 35.07 Million CAD | -58.098% |
| Canopy Growth Corporation | 80.88 Million CAD | 31.443% |
| Willow Biosciences Inc. | -659 Thousand CAD | 8514.264% |
| Auxly Cannabis Group Inc. | 21.27 Million CAD | -160.61% |